Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A for head/forehead hyperhidrosis
jRCTs041180084Completed
- Start
- Sep 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in Primary hyperhidrosis (PH). Primary endpoint: Primary responder rate at 6 weeks by objective sweat measurements. Started Sep 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Primary hyperhidrosis (PH)
Beyond the preview
Go deeper on jRCTs041180084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180084.